Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01155986Phase 2Terminated
A Phase 2 trial of lidocaine 10% oropharyngeal spray in neuropathic pain, sponsored by Grünenthal GmbH. Started Aug 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01155986.